AI-generated · cited to primary sources · not investment advice
Unihealth Hosp (UNIHEALTH) Mar 2025 Filing Analysis
How durable is the business?
The core hospital segment remains the dominant revenue driver, growing 14% year-over-year and maintaining a high revenue share of 82.19%. (2 expanding, 1 shifted)
“In FY25, Unihealth Hospitals Limited sustained its growth trajectory... Total Income (Hospital segment) FY24 (₹ Cr) 48.75, FY25 (₹ Cr) 55.59, YoY Growth 14.0%”
See the full cited Business Model analysis of Unihealth Hosp
What could break the thesis?
The risk is easing as net profit margins actually improved to 26% in FY25 (up from 20.47% in FY24). Management also aims to become debt-free in existing businesses by the end of FY26, which will mitigate interest cost pressures. (2 easing)
“EBITDA margins remained robust at 36%, and net profit margins improved to 26%, underscoring our focus on operational efficiency, cost discipline, and sustainable growth.”
See the full cited Risk analysis of Unihealth Hosp
AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.